Su questa pagina
KALA KALA BIO, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 19, 2026
$0,39
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,10minimo 52 sett.
$5,88massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$7M
P/E
-0.0
EPS
$-3.31
Ricavi
$0
i tuoi badge
Intervallo 52 sett.
$0–$6
Rating Analisti
HOLD
Prezzo Obiettivo
·
P/E
-0.0
ROE
-1423.8%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
KALA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.39
Capitalizzazione di Mercato (MRQ)
$7M
P/E
-0.0
EPS
$-3.31
Ricavi
$0
ROE
-1423.8%
Intervallo 52 sett.
$0–$6
KALA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 11 Maggio 2026 | 1-for-50 | Inverso |
| 21 Ottobre 2022 | 1-for-50 | Inverso |
Informazioni su KALA BIO, Inc. - Common Stock Panoramica della società da Wikipedia
settoreHealthcare
industriaBiotechnology
dipendenti6
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02016-12-31 → 2025-12-31
EPS$-3.312020-12-31 → 2025-12-31
Flusso di cassa libero·2017-12-31 → 2019-12-31
Margine netto·2019-12-31 → 2022-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | KALA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.0media 5 anni ≈-0.6 | ≈-0.6 | · | · | |
| P/B (MRQ) | 0.8media 5 anni ≈49.5 | ≈49.5 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -0.0media 5 anni ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.0media 5 anni ≈49.5 | ≈49.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | KALA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -83.0%media 5 anni ≈-66.0% | ≈-66.0% | -134.9% | Di prim'ordine | |
| ROE | -1423.8%media 5 anni ≈-627.6% | ≈-627.6% | -412.8% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | KALA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 6.9media 5 anni ≈4.0 | ≈4.0 | 2.6 | Liquidità elevata | |
| Quick Ratio | 3.0media 5 anni ≈3.6 | ≈3.6 | 2.0 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | KALA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
30.9%
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 31 Dicembre 2025 | $-33.50 | $-73.44 | 54.4% | |
| 30 Settembre 2025 | $-43.00 | $-73.72 | 41.7% | |
| 30 Giugno 2025 | $-85.50 | $-86.87 | 1.6% | |
| 31 Marzo 2025 | $-70.50 | $-103.53 | 31.9% | |
| 31 Dicembre 2024 | $-1.74 | $-2.33 | 25.2% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $4M | $11M | $6M | $6M | · | $0 | $0 | |
| R&D Expense | · | · | · | · | · | $18M | $27M | $29M | $29M | $25M | |
| SG&A Expense | $24M | $18M | $21M | $65M | $105M | $81M | $65M | $35M | $11M | $8M | |
| Operating Expenses | $39M | $41M | $40M | $86M | $141M | $103M | $94M | $65M | $40M | $33M | |
| Operating Income | $-39M | $-41M | $-40M | $-82M | $-130M | $-96M | $-88M | $-65M | $-40M | $-33M | |
| Interest Expense | · | · | $6M | $7M | $8M | $9M | $8M | $3M | $1M | $767.0K | |
| Interest Income | $1M | $2M | $3M | $664.0K | $104.0K | $493.0K | $2M | $2M | $527.0K | $147.0K | |
| Other Non-op | $5M | · | $-4M | $-926.0K | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-27M | $-39M | $-42M | $-45M | $-143M | $-104M | $-94M | $-67M | $-42M | $-33M | |
| EPS (Basic) | $-3.31 | $-10.15 | $-17.35 | $-29.48 | $-108.32 | $-1.99 | · | · | · | · | |
| EPS (Diluted) | $-3.31 | $-10.15 | $-17.35 | $-29.48 | $-108.32 | $-1.99 | · | · | · | · | |
| Shares (Basic) | 8,148,275 | 3,796,047 | 2,432,008 | 1,520,611 | 1,316,495 | 52,377,526 | · | · | · | · | |
| Shares (Diluted) | 8,148,275 | 3,796,047 | 2,432,008 | 1,520,611 | 1,316,495 | 52,377,526 | · | · | · | · | |
| EBITDA | $-39M | $-41M | $-39M | $-81M | $-129M | $-95M | $-88M | $-65M | $-40M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $51M | $51M | $70M | $92M | $77M | $85M | $171M | $115M | $45M | |
| Short-term Investments | · | · | · | · | · | $76M | · | · | · | · | |
| Receivables | · | · | · | $195.0K | $15M | $10M | $12M | · | · | · | |
| Inventory | · | · | · | · | $9M | $5M | $5M | $4M | · | · | |
| Prepaid Expense | $2M | $2M | $2M | $8M | $6M | $3M | $4M | $2M | $648.0K | $154.0K | |
| Other Current Assets | · | · | · | · | · | · | · | $477.0K | $196.0K | $41.0K | |
| Current Assets | $9M | $53M | $53M | $86M | $124M | $171M | $105M | $177M | $115M | $46M | |
| PP&E (Net) | · | $749.0K | $753.0K | $400.0K | $3M | $3M | $3M | $2M | $786.0K | $594.0K | |
| PP&E (Gross) | $869.0K | $2M | $2M | $2M | $6M | $7M | $5M | $4M | $2M | $2M | |
| Accum. Depreciation | $869.0K | $1M | $1M | $1M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Total Assets | $9M | $55M | $56M | $87M | $139M | $222M | $154M | $221M | $117M | $46M | |
| Accounts Payable | $986.0K | $628.0K | $919.0K | $3M | $5M | $2M | $3M | $5M | $1M | $997.0K | |
| Accrued Liabilities | · | · | $6M | $9M | $21M | $19M | $21M | $11M | $7M | $4M | |
| Current Liabilities | $2M | $17M | $8M | $26M | $37M | $22M | $25M | $17M | $15M | $6M | |
| Capital Leases | · | $1M | $2M | · | $548.0K | · | · | $29M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $8.0K | $17.0K | |
| Total Liabilities | $2M | $43M | $48M | $68M | $123M | $122M | $125M | $116M | $27M | $16M | |
| Long-term Debt | · | $29M | $34M | $43M | $80M | $75M | $75M | $75M | $19M | $10M | |
| Total Debt | · | $30M | $34M | $43M | $79M | $72M | $71M | $70M | $19M | · | |
| Common Stock | $1.0K | $6.0K | $3.0K | $2.0K | $1.0K | $59.0K | $36.0K | $34.0K | $25.0K | $1.0K | |
| Paid-in Capital | $702M | $680M | $637M | $606M | $559M | $500M | $325M | $306M | $224M | $4M | |
| Retained Earnings | $-695M | $-668M | $-629M | $-587M | $-542M | $-400M | $-295M | $-201M | $-134M | $-92M | |
| AOCI | · | · | · | · | · | $4.0K | · | · | · | · | |
| Stockholders' Equity | $7M | $12M | $8M | $19M | $17M | $100M | $30M | $105M | $90M | $-88M | |
| Liabilities + Equity | $9M | $55M | $56M | $87M | $139M | $222M | $154M | $221M | $117M | $46M | |
| Shares Outstanding | 556,995 | 6,091,182 | 2,759,372 | 1,706,971 | 1,322,464 | 58,915,375 | 36,086,254 | 33,863,077 | 24,538,309 | 1,181,429 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $317.0K | $259.0K | $303.0K | $537.0K | $975.0K | $912.0K | $843.0K | · | · | · | |
| Stock-based Comp | $7M | $8M | $7M | $7M | $16M | $13M | $10M | $9M | $4M | $2M | |
| Other Non-cash | $-12M | $481.0K | $7M | $-42M | $17M | $-591.0K | · | · | · | · | |
| Operating Cash Flow | $-32M | $-29M | $-28M | $-79M | $-108M | $-91M | $-93M | $-54M | $-34M | $-27M | |
| CapEx | · | · | · | · | · | · | $1M | $2M | $480.0K | $153.0K | |
| Investing Cash Flow | $-15.0K | $-208.0K | $-429.0K | $63M | $71M | $-78M | $-1M | $-2M | $-480.0K | $-153.0K | |
| Debt Issued | · | · | · | · | $78M | · | · | $72M | $10M | $1M | |
| Net Debt Issued | · | · | · | · | $78M | · | · | $72M | $10M | · | |
| Stock Issued | $9M | $3M | $19M | $1M | $41M | $159M | $8M | $30M | $30M | · | |
| Net Stock Activity | $9M | $3M | $19M | $1M | $41M | $159M | · | $30M | $30M | · | |
| Financing Cash Flow | $-12M | $30M | $9M | $-8M | $43M | $161M | $9M | $124M | $104M | $67M | |
| Net Change in Cash | $-44M | $286.0K | $-20M | $-24M | $5M | $-8M | $-85M | $68M | $69M | $40M | |
| Free Cash Flow | · | · | · | · | · | · | $-94M | $-56M | $-35M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -2099.3% | -1158.8% | -1512.6% | -1452.5% | · | · | · | |
| Net Margin | · | · | · | -1151.6% | -1268.7% | -1639.8% | -1553.3% | · | · | · | |
| EBITDA Margin | · | · | · | -2085.5% | -1150.1% | -1498.3% | -1452.5% | · | · | · | |
| ROA | -83.0% | -69.1% | -59.1% | -39.6% | -79.0% | -55.5% | -50.3% | -39.6% | -52.0% | · | |
| ROE | -1423.8% | -401.3% | -450.7% | -497.9% | -364.4% | -101.3% | -207.9% | -83.5% | -4403.9% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.1 | 6.3 | 3.3 | 3.3 | 7.7 | 4.3 | 10.4 | 8.0 | · | |
| Quick Ratio | 3.0 | 3.0 | 6.1 | 2.8 | 2.9 | 7.3 | 3.9 | 10.0 | 7.9 | · | |
| Debt / Equity | · | 2.5 | 4.6 | 2.3 | 4.7 | 0.7 | 2.4 | 0.7 | 0.2 | · | |
| LT Debt / Equity | · | 1.6 | 4.6 | 2.0 | 4.7 | 0.7 | 2.4 | 0.7 | 0.1 | · | |
| Interest Coverage | · | · | -6.8 | -11.2 | -15.5 | -11.2 | -10.4 | -19.5 | -39.1 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | 0.0 | · | |
| Receivables Turnover | · | · | · | 0.5 | 0.9 | 0.6 | 1.1 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.25 | $2.02 | $2.72 | $11.12 | $0.26 | $1.70 | $0.82 | $3.10 | $3.65 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $2.56 | $0.17 | · | · | · | · | · | |
| Cash Flow / Share | $-3.93 | $-7.74 | $-11.48 | $-51.89 | $-1.66 | · | · | · | · | · | |
| Cash / Share | $0.27 | $8.40 | $18.44 | $41.30 | $1.41 | $1.31 | $2.37 | $5.05 | $4.67 | · | |
| EPS (TTM) | $-3.31 | $-10.15 | $-17.35 | $-29.48 | $-108.32 | $-1.99 | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -65.4% | 76.7% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $4M | $11M | $6M | $6M | · | $0 | · | |
| Net Income TTM | $-27M | $-39M | $-42M | $-45M | $-143M | $-104M | $-94M | $-67M | $-42M | · | |
| Market Cap | $15M | $42M | $19M | $65M | $3.96B | $19.97B | $6.66B | $8.28B | $22.69B | · | |
| Enterprise Value | · | $22M | $3M | $38M | $3.95B | $19.89B | $6.64B | $8.18B | $22.59B | · | |
| P/E | -0.2 | -0.7 | -0.4 | -1.3 | -0.6 | -170.4 | · | · | · | · | |
| P/S | · | · | · | 16.7 | 352.6 | 3139.3 | 1096.1 | · | · | · | |
| P/B | 2.2 | 3.4 | 2.6 | 3.4 | 235.8 | 199.7 | 224.2 | 78.9 | 253.0 | · | |
| P / Tangible Book | 2.2 | 3.4 | 2.6 | 3.4 | 235.8 | 199.7 | · | · | · | · | |
| P / Cash Flow | -0.5 | -1.4 | -0.7 | -0.8 | -36.6 | -220.2 | -71.8 | -153.0 | -665.3 | · | |
| P / FCF | · | · | · | · | · | · | -70.8 | -148.6 | -656.1 | · | |
| EV / EBITDA | · | -0.5 | -0.1 | -0.5 | -30.6 | -208.7 | -75.3 | -126.4 | -566.5 | · | |
| EV / FCF | · | · | · | · | · | · | -70.6 | -146.8 | -653.3 | · | |
| EV / Revenue | · | · | · | 9.7 | 351.4 | 3126.5 | 1093.8 | · | · | · | |
| Earnings Yield | -595.3% | -146.2% | -247.9% | -77.3% | -179.0% | -0.59% | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $420.0K | |
| R&D Expense | $59.0K | $61.0K | · | $6M | $6M | $6M | · | $5M | $5M | $6M | · | $6M | $4M | $4M | · | $5M | |
| SG&A Expense | $2M | $2M | $10M | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $10M | |
| Operating Expenses | $2M | $2M | $10M | $7M | $11M | $11M | $9M | $10M | $10M | $12M | $10M | $9M | $10M | $12M | $10M | $15M | |
| Operating Income | $-2M | $-2M | $-10M | $-7M | $-11M | $-11M | $-9M | $-10M | $-10M | $-12M | $-10M | $-9M | $-10M | $-12M | $-10M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $1M | $1M | $2M | $1M | |
| Interest Income | $140.0K | $74.0K | $0 | $270.0K | $407.0K | $463.0K | $478.0K | $570.0K | $504.0K | $504.0K | $610.0K | $708.0K | $718.0K | $675.0K | $354.0K | $234.0K | |
| Other Non-op | $0 | $107.0K | $4M | $-112.0K | $-127.0K | $2M | · | · | $26.0K | $124.0K | $-5.0K | $-2M | $-119.0K | $-2M | $-1M | $443.0K | |
| Net Income | $-2M | $-2M | $686.0K | $-8M | $-11M | $-9M | $-8M | $-9M | $-10M | $-12M | $-9M | $-9M | $-10M | $-14M | $-13M | $29M | |
| EPS (Basic) | $-21.32 | $-0.14 | $0.88 | $-1.07 | $-85.64 | $-70.49 | $-0.86 | $-1.93 | $-3.16 | $-4.20 | $-2.59 | $-3.41 | $-4.36 | $-6.99 | $-7.77 | $19.39 | |
| EPS (Diluted) | $-21.32 | $-0.14 | $0.88 | $-1.07 | $-85.64 | $-70.49 | $-0.86 | $-1.93 | $-3.16 | $-4.20 | $-2.59 | $-3.41 | $-4.36 | $-6.99 | $-7.63 | $19.25 | |
| Shares (Basic) | 74,159 | 11,873,568 | · | 7,042,457 | 130,262 | 126,917 | · | 4,627,578 | 3,030,213 | 2,813,210 | · | 2,550,210 | 2,387,793 | 2,069,186 | · | 1,499,001 | |
| Shares (Diluted) | 74,159 | 11,873,568 | · | 7,042,457 | 130,262 | 126,917 | · | 4,627,578 | 3,030,213 | 2,813,210 | · | 2,550,210 | 2,387,793 | 2,069,186 | · | 1,510,421 | |
| EBITDA | $-2M | $-2M | · | $-7M | $-11M | $-11M | · | $-10M | $-10M | $-12M | · | $-9M | $-10M | $-12M | · | $-15M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $229.0K | $2M | $8M | $21M | $32M | $42M | $51M | $49M | $54M | $48M | $51M | $56M | $49M | $64M | $70M | $52M | |
| Short-term Investments | $7M | $7M | · | · | · | · | · | · | · | · | · | · | $10M | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $190.0K | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $3M | $4M | $2M | $3M | $2M | $3M | $2M | $2M | $5M | $2M | $2M | $2M | $1M | $2M | $8M | $23M | |
| Current Assets | $11M | $12M | $9M | $24M | $34M | $46M | $53M | $51M | $59M | $50M | $53M | $58M | $66M | $71M | $86M | $85M | |
| PP&E (Net) | · | · | · | $603.0K | $657.0K | $695.0K | $749.0K | $762.0K | $617.0K | $714.0K | $753.0K | $802.0K | $637.0K | $504.0K | $400.0K | $517.0K | |
| PP&E (Gross) | · | · | $869.0K | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $869.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Total Assets | $11M | $12M | $9M | $25M | $36M | $48M | $55M | $54M | $62M | $53M | $56M | $61M | $66M | $72M | $87M | $86M | |
| Accounts Payable | $1M | $1M | $986.0K | $917.0K | $658.0K | $931.0K | $628.0K | $711.0K | $665.0K | $732.0K | $919.0K | $787.0K | $760.0K | $997.0K | $3M | $7M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $4M | $4M | $5M | · | $6M | $5M | $5M | $9M | $25M | |
| Current Liabilities | $2M | $2M | $2M | $33M | $16M | $23M | $17M | $24M | $19M | $12M | $8M | $10M | $10M | $10M | $26M | $40M | |
| Capital Leases | · | · | · | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | |
| Total Liabilities | $2M | $2M | $2M | $34M | $39M | $43M | $43M | $47M | $48M | $46M | $48M | $50M | $49M | $49M | $68M | $87M | |
| Long-term Debt | · | · | · | $27M | $27M | $29M | $29M | $34M | $34M | $34M | · | $34M | $34M | $34M | $43M | · | |
| Total Debt | · | · | · | $28M | $28M | $31M | · | $35M | $35M | $35M | · | $34M | $34M | $33M | · | $43M | |
| Common Stock | $20.0K | $19.0K | $28.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $707M | $707M | $702M | $687M | $685M | $683M | $680M | $667M | $665M | $648M | $637M | $632M | $630M | $625M | $606M | $573M | |
| Retained Earnings | $-698M | $-697M | $-695M | $-696M | $-688M | $-677M | $-668M | $-660M | $-651M | $-641M | $-629M | $-621M | $-612M | $-602M | $-587M | $-574M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $9.0K | · | · | · | |
| Stockholders' Equity | $9M | $11M | $7M | $-9M | $-3M | $6M | $12M | $7M | $14M | $7M | $8M | $11M | $17M | $23M | $19M | $-968.0K | |
| Liabilities + Equity | $11M | $12M | $9M | $25M | $36M | $48M | $55M | $54M | $62M | $53M | $56M | $61M | $66M | $72M | $87M | $86M | |
| Shares Outstanding | 19,339,786 | 18,589,832 | 27,849,725 | 7,432,925 | 6,679,115 | 6,452,398 | 6,091,182 | 4,610,139 | 4,598,419 | 2,816,454 | 2,759,372 | 2,693,116 | 2,538,687 | 2,309,287 | 1,706,971 | 1,476,637 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $54.0K | $128.0K | $67.0K | $68.0K | $69.0K | $63.0K | $61.0K | $66.0K | $70.0K | $79.0K | $77.0K | $77.0K | $80.0K | $151.0K | |
| Stock-based Comp | $-136.0K | $-471.0K | $401.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $960.0K | $1M | |
| Other Non-cash | · | · | · | · | · | $-2M | · | · | · | $-1M | · | · | · | $3M | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-5M | $-11M | $-17M | $-9M | $-5M | $-5M | $-9M | $-11M | $-8M | $-3M | $-8M | $-10M | $-14M | $-16M | |
| Investing Cash Flow | $0 | $-7M | $0 | $1.0K | · | · | $-69.0K | $-90.0K | $-36.0K | $-13.0K | $-7.0K | $10M | $-10M | $-108.0K | $51.0K | $65M | |
| Stock Issued | · | · | · | · | · | · | $923.0K | $0 | · | · | $570.0K | $0 | $3M | $15M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | · | |
| Financing Cash Flow | $0 | $4M | $-9M | $30.0K | $-3M | $-135.0K | $7M | $-180.0K | $15M | $8M | $3M | $40.0K | $3M | $3M | $32M | $-40M | |
| Net Change in Cash | $-2M | $-6M | $-14M | $-11M | $-10M | $-9M | $2M | $-5M | $6M | $-2M | $-5M | $7M | $-15M | $-7M | $18M | $9M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -3468.8% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 6922.1% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -3468.8% | |
| ROA | -6.8% | -5.3% | · | -19.1% | -22.8% | -17.7% | · | -15.5% | -14.9% | -18.9% | · | -11.9% | -13.8% | -15.7% | · | 20.8% | |
| ROE | -54.2% | -19.7% | · | 837.6% | -212.2% | -144.7% | · | -99.0% | -61.4% | -78.4% | · | -169.8% | 148.1% | -159.1% | · | 96.1% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 7.9 | · | 0.7 | 2.1 | 2.0 | · | 2.1 | 3.1 | 4.2 | · | 5.6 | 6.7 | 7.0 | · | 2.1 | |
| Quick Ratio | 4.7 | 5.6 | · | 0.6 | 2.0 | 1.8 | · | 2.1 | 2.8 | 4.1 | · | 5.4 | 6.0 | 6.2 | · | 1.3 | |
| Debt / Equity | · | · | · | -3.3 | -8.8 | 5.4 | · | 5.1 | 2.5 | 5.2 | · | 3.0 | 1.9 | 1.4 | · | -44.1 | |
| LT Debt / Equity | · | · | · | · | -5.9 | 2.6 | · | 2.5 | 1.7 | 4.3 | · | 3.0 | 1.9 | 1.4 | · | -44.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -8.2 | · | -6.0 | -6.8 | -7.9 | · | -10.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.47 | $0.58 | · | $-1.17 | $-0.48 | $0.88 | · | $1.49 | $2.98 | $2.37 | · | $4.17 | $6.89 | $10.16 | · | $-0.66 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.28 | |
| Cash Flow / Share | · | $-0.24 | · | · | $-2.54 | $-1.39 | · | · | · | $-3.85 | · | · | · | $-4.68 | · | · | |
| Cash / Share | $0.01 | $0.09 | · | $2.84 | $4.78 | $6.54 | · | $10.67 | $11.79 | $17.21 | · | $20.82 | $19.40 | $27.56 | · | $35.48 | |
| EPS (TTM) | $-21.65 | $-85.97 | · | $-158.06 | $-158.92 | $-76.44 | · | $-11.88 | $-13.36 | $-14.56 | · | $-22.39 | $0.27 | $-14.29 | · | $-107.70 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $6M | |
| Net Income TTM | $-10M | $-20M | · | $-36M | $-37M | $-36M | · | $-39M | $-39M | $-40M | · | $-46M | $-9M | $-26M | · | $-80M | |
| Market Cap | $33M | $3M | · | $11M | $32M | $37M | · | $26M | $33M | $22M | · | $24M | $37M | $35M | · | $16M | |
| Enterprise Value | · | · | · | $19M | $28M | $25M | · | $12M | $13M | $8M | · | $2M | $11M | $4M | · | $7M | |
| P/E | -0.1 | -0.0 | · | -0.0 | -0.0 | -0.1 | · | -0.5 | -0.5 | -0.5 | · | -0.4 | 54.0 | -1.1 | · | -0.1 | |
| P/S | 8.6 | 0.8 | · | 2.9 | 8.2 | 9.5 | · | 6.8 | 8.4 | 5.8 | · | 6.2 | 9.5 | 8.9 | · | 2.8 | |
| P/B | 3.7 | 0.3 | · | -1.3 | -9.9 | 6.5 | · | 3.8 | 2.4 | 3.4 | · | 2.1 | 2.1 | 1.5 | · | -16.9 | |
| P / Tangible Book | 3.7 | 0.3 | · | · | · | 6.5 | · | 3.8 | 2.4 | 3.4 | · | 2.1 | 2.1 | 1.5 | · | · | |
| P / Cash Flow | · | -1.1 | · | · | -1.9 | -4.2 | · | · | · | -2.1 | · | · | · | -3.6 | · | · | |
| EV / Revenue | · | · | · | 4.8 | 7.2 | 6.5 | · | 3.1 | 3.4 | 2.2 | · | 0.5 | 2.9 | 1.1 | · | 1.1 | |
| Earnings Yield | -1251.5% | -49693.6% | · | -10330.7% | -3338.7% | -1334.0% | · | -208.4% | -188.4% | -182.7% | · | -251.6% | 1.8% | -95.0% | · | -974.7% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $0 | $0 | $0 | $4M | $11M |
| Margine Operativo % | · | · | · | -2099.3% | -1158.8% |
| Utile netto | $-27M | $-39M | $-42M | $-45M | $-143M |
| EPS Diluito | $-3.31 | $-10.15 | $-17.35 | $-29.48 | $-108.32 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | 2.5 | 4.6 | 2.3 | 4.7 |
| Rapporto corrente | 3.8 | 3.1 | 6.3 | 3.3 | 3.3 |
| Quick Ratio | 3.0 | 3.0 | 6.1 | 2.8 | 2.9 |
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 4 filer · $51K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
4
Valore detenuto
$51K
Nuove posizioni
0
Posizioni chiuse
29
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 0 | 29 | 0 | 1 | · |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata. Variazione vs trimestre precedente non mostrata: la copertura dei dichiaranti differisce troppo tra questi due trimestri per un confronto affidabile.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $50.601 | 91.009 | 99,76% | Azioni |
| Legacy Investment Solutions, LLC | $119 | 25 | 0,23% | Azioni |
| HARBOUR INVESTMENTS, INC. | $5 | 3 | 0,01% | Azioni |
| Motiv8 Investments LLC | $0 | 2 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 7 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Lazar David E. ×2 depositi | 02 Luglio 2026 | 3,90% | Modifica | · | SEC |
| SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, SR One Capital Management, LLC, Simeon George ×3 depositi | 15 Ottobre 2025 | 4,60% | Modifica | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×3 depositi | 02 Ottobre 2025 | 9,99% | Modifica | Campagna per il consiglio di amministrazione | SEC |
| Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×4 depositi | 18 Ottobre 2023 | · | Deposito iniziale | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×6 depositi | 03 Giugno 2022 | · | Deposito iniziale | · | SEC |
| Lagunita Biosciences, LLC, Lagunita, LLC, Garland Investments, L.P., Mark S. Blumenkranz ×3 depositi | 26 Novembre 2021 | · | Deposito iniziale | M&A / vendita | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×2 depositi | 05 Ottobre 2018 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 22 insider · 6 dirigenti · 15 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lazar David E. | Chief Executive Officer | 18 Dicembre 2025 J | · | 0 | 0 | $0 |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 23 Ottobre 2025 S | 28.906 | 0 | 2 | $-27.544 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 22 Ottobre 2025 S | 41.760 | 0 | 1 | $-17.269 |
| Eric Trachtenberg | Chief Legal Officer, Chief Compliance Officer and Secretary | 04 Gennaio 2024 A | 68.066 | 0 | 0 | $0 |
| Hongming Chen | CHIEF SCIENTIFIC OFFICER | 27 Ottobre 2021 S | 204.515 | 0 | 0 | $0 |
| Michele Larussa | Sr. VP, Regulatory and Quality | 07 Febbraio 2018 A | · | 0 | 0 | $0 |
| Mark T Iwicki | Direttore | 23 Ottobre 2025 S | 103.540 | 0 | 1 | $-125.464 |
| Todd Bazemore | Direttore | 22 Ottobre 2025 S | 35.932 | 0 | 1 | $-39.647 |
| Marjan Farid | Direttore | 15 Giugno 2025 A | 10.242 | 0 | 0 | $0 |
| Daniel C. Myers | Direttore | 15 Giugno 2025 A | 10.374 | 0 | 0 | $0 |
| Howard B Rosen | Direttore | 15 Giugno 2025 A | 16.240 | 0 | 0 | $0 |
| Andrew I Koven | Direttore | 15 Giugno 2025 A | 16.972 | 0 | 0 | $0 |
| Gregory D Perry | Direttore | 15 Giugno 2025 A | 13.344 | 0 | 0 | $0 |
| Mark S. Blumenkranz | Direttore | 11 Giugno 2024 A | 13.091 | 0 | 0 | $0 |
| Robert Bradley Paull | Direttore | 16 Giugno 2022 A | 40.000 | 0 | 0 | $0 |
| Gregory Grunberg | Direttore | 17 Giugno 2021 A | 40.000 | 0 | 0 | $0 |
| Rajeev Shah | Direttore | 17 Giugno 2021 A | 20.000 | 0 | 0 | $0 |
| Hill Paulina | Direttore | 12 Giugno 2018 A | · | 0 | 0 | $0 |
| Robert Langer | Direttore | 12 Giugno 2018 A | · | 0 | 0 | $0 |
| Robert I Tepper | Direttore | 25 Luglio 2017 C | 1.621.092 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) L.P. | Proprietario del 10% | 25 Luglio 2017 C | 846.566 | 0 | 0 | $0 |
| Romulus K Brazzell | · | 22 Ottobre 2025 S | 35.952 | 0 | 1 | $-38.801 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 220.623 SH | 19 Agosto 2026 | Giornaliero |
KALA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 6 analisti
VENDI
0 0,0%
Acquisto forte
0 0,0%
Compra
3 50,0%
Mantieni
1 16,7%
Vendi
2 33,3%
Vendita forte
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| KALA | $15M | -0.2 | · | · | -1423.8% | · |
| OSRH | · | · | · | · | · | · |
| SNGX | $14M | -0.6 | -85.8% | · | -311.2% | · |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | · |
| FBLG | · | -0.5 | · | · | · | · |
| IMNN | $13M | -0.6 | · | · | -298.2% | · |
| SKYE | $25M | -0.5 | · | · | -175.6% | · |
| ACXP | $6M | -0.5 | · | · | -180.3% | · |
| BIAF | · | · | · | · | · | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 19, 2026